[go: up one dir, main page]

WO2013144663A3 - Method of determination of neutral dna sequences in the genome, system for targeting sequences obtained thereby and methods for use thereof - Google Patents

Method of determination of neutral dna sequences in the genome, system for targeting sequences obtained thereby and methods for use thereof Download PDF

Info

Publication number
WO2013144663A3
WO2013144663A3 PCT/HR2013/000003 HR2013000003W WO2013144663A3 WO 2013144663 A3 WO2013144663 A3 WO 2013144663A3 HR 2013000003 W HR2013000003 W HR 2013000003W WO 2013144663 A3 WO2013144663 A3 WO 2013144663A3
Authority
WO
WIPO (PCT)
Prior art keywords
genome
interest
dna
neutral
determination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/HR2013/000003
Other languages
French (fr)
Other versions
WO2013144663A2 (en
Inventor
Ivica RUBELJ
Tomislav DOMAZET-LOSO
Robert BAKARIC
Milena IVANKOVIC
Nikolina SKROBOT VIDACEK
Andrea CUKUSIC KALAJZIC
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RUDJER BOSKOVIC INSTITUTE
Boskovic Rudjer Institute
Original Assignee
RUDJER BOSKOVIC INSTITUTE
Boskovic Rudjer Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RUDJER BOSKOVIC INSTITUTE, Boskovic Rudjer Institute filed Critical RUDJER BOSKOVIC INSTITUTE
Publication of WO2013144663A2 publication Critical patent/WO2013144663A2/en
Publication of WO2013144663A3 publication Critical patent/WO2013144663A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/10—Ontologies; Annotations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to the method for identification of neutral DNA sequences suitable for integration of DNA of interest in any partially or completely annotated sequence or genome. The invention further relates to the identified neutral sequences which are suitable for integration of DNA of interest, the method for inserting a DNA of interest into the genome of interest. Furthermore, the invention relates to the cell and/or organ ism which have integrated DNA of interest in the neutral sequence and their use in the production of cell lines, transgenic plants and animals and for gene therapy.
PCT/HR2013/000003 2012-03-27 2013-03-26 Method of determination of neutral dna sequences in the genome, system for targeting sequences obtained thereby and methods for use thereof Ceased WO2013144663A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261616284P 2012-03-27 2012-03-27
US61/616,284 2012-03-27

Publications (2)

Publication Number Publication Date
WO2013144663A2 WO2013144663A2 (en) 2013-10-03
WO2013144663A3 true WO2013144663A3 (en) 2014-04-17

Family

ID=48468672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HR2013/000003 Ceased WO2013144663A2 (en) 2012-03-27 2013-03-26 Method of determination of neutral dna sequences in the genome, system for targeting sequences obtained thereby and methods for use thereof

Country Status (1)

Country Link
WO (1) WO2013144663A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ735257A (en) 2013-11-04 2018-09-28 Dow Agrosciences Llc Optimal soybean loci
WO2015066636A2 (en) 2013-11-04 2015-05-07 Dow Agrosciences Llc Optimal maize loci
JP6633532B2 (en) 2013-11-04 2020-01-22 ダウ アグロサイエンシィズ エルエルシー Optimal corn loci
WO2015066634A2 (en) * 2013-11-04 2015-05-07 Dow Agrosciences Llc Optimal soybean loci
CN110556165B (en) * 2019-09-12 2022-03-18 浙江大学 Method for rapidly identifying transgene or gene editing material and insertion site thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2385477A1 (en) * 2004-07-02 2011-11-09 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE NAVY Computer-implemented method, computer readable storage medium and apparatus for identification of a biological sequence

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2385477A1 (en) * 2004-07-02 2011-11-09 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE NAVY Computer-implemented method, computer readable storage medium and apparatus for identification of a biological sequence

Also Published As

Publication number Publication date
WO2013144663A2 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
MX356625B (en) Oligonucleotides for making a change in the sequence of a target rna molecule present in a living cell.
SG10201510189WA (en) Compositions And Methods For Directional Nucleic Acid Amplification And Sequencing
IL231460A0 (en) 5-methoxy 3' - oh unblocked, fast photocleavable terminating nuleotides and methods for nucleic acid sequencing
WO2014172470A3 (en) Methods of mutating, modifying or modulating nucleic acid in a cell or nonhuman mammal
WO2013127782A3 (en) Use of micro-rnas or genes as markers for the identification, diagnosis and therapy of individual forms of non-ischemic cardiomyopathies or storage diseases of the heart
WO2014014991A3 (en) Methods of storing information using nucleic acids
WO2012075040A3 (en) mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
DK3250691T3 (en) HYBRID CRISPR DNA/RNA POLYNUCLEOTIDES AND METHODS OF THEIR USE
GB2494239B (en) Nucleic acid amplification
GB201209132D0 (en) Compositions and methods for targeted nucleic acid sequence selection and amplification
MY161583A (en) Synthetic genes
UA118090C2 (en) Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
PL3401400T3 (en) Method and Compositions for Modifying a Target DNA by Targeting RNA and for Modulating Transcription by Targeting RNA
SG10201710631RA (en) Artificial nucleic acid molecules for improved protein or peptide expression
WO2012092580A3 (en) Nucleic acid molecules that target the vacuolar atpase h subunit and confer resistance to coleopteran pests
EA201391373A1 (en) METHODS OF OBTAINING A COMPLEX LOCUS OF TRANSGENIC SIGNS
WO2012092596A3 (en) Nucleic acid molecules that target the rho1 small gtp-binding protein and confer resistance to coleopteran pests
PH12014500539A1 (en) Regulatory nucleic acid molecules for reliable gene expression in plants
ZA201407220B (en) Methods for preparing samples for nucleic acid amplification
WO2011106541A3 (en) Diagnostic methods involving loss of heterozygosity
WO2012092573A3 (en) Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests
WO2014017493A9 (en) Vaccine
BR112014010451A2 (en) methods for controlling vegetation, for identifying an herbicide and for identifying a nucleotide sequence, isolated nucleic acid, transgenic plant cell, transgenic plant, plant, seed, methods of producing a transgenic plant cell and identifying or selecting a transformed plant cell
WO2012135468A3 (en) Genetics of gender discrimination in date palm
CL2014000206A1 (en) Isolated nucleotide sequence encoding the enolpiruvilshikimato-3 phosphate synthetase (epsps); kit to detect maize genetic transformation event vco-01981-5; method to produce glyphosate tolerant plant.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13723948

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13723948

Country of ref document: EP

Kind code of ref document: A2